Delivery Order SPE2DB20D3101-SPE2DB24FRNL7

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $3,006.12 for the provision of VISCOAT SYRINGE 0.75ML medical supplies. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distribution company that has a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award, valued at $8,870.58, was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of 0.75 mL "VISCOAT SYRINGE" medical supplies. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,666.80 firm fixed price delivery order is for the supply of 0.5mL VISCOAT syringes, with a completion date of November 15, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,666.80 firm fixed price contract is for the delivery of VISCOAT SYRINGE 0.5ML products, with a completion date of February 18, 2025. The contract is a delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,731.80 firm fixed-price delivery order is for the provision of 0.5 ml "VISCOAT SYRINGE" medical devices. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award, valued at $2,333.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 0.5mL VISCOAT syringes, with a completion date of November 14, 2024. This award is part of an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $3,403.91 for the provision of 0.5 mL VISCOAT syringes. The contract is a Firm Fixed Price vehicle awarded by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of May 23, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary means...
This federal contract award is a delivery order with a firm fixed price of $11,523.46 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 0.75 mL VISCOAT syringes, with a period of performance through January 14, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is a delivery order valued at $3,033.45 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract was awarded by the Defense Logistics Agency, a defense agency, to provide 0.5ML VISCOAT syringes. The contract is a firm fixed price arrangement with a completion date of June 25, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,555.60 for the provision of VISCOAT SYRINGE 0.5ML. The contract has an ultimate completion date of June 17, 2024 and was awarded on June 14, 2022 by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRNL7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,889.00 Delivery Order contract is for the provision of 0.5mL "VISCOAT SYRINGE" medical supplies.

Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

The contract award was made on a full and open competition basis without any set-aside designation. As a leading supplier of pharmaceutical and medical products to federal agencies, Amerisourcebergen leverages its extensive supply chain network to fulfill these government contracts.

Generated 9/23/24, 10:08 AM